ArticleBMJ open2023

Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study): a multicentre open-label non-randomised clinical trial.

Masahiro Takeyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.